GRADE Concept 7: Issues and Insights Linking Guideline Recommendations to Trustworthy Essential Medicine Lists.

GRADE drug coverage essential medicines

Journal

Journal of clinical epidemiology
ISSN: 1878-5921
Titre abrégé: J Clin Epidemiol
Pays: United States
ID NLM: 8801383

Informations de publication

Date de publication:
18 Dec 2023
Historique:
received: 24 08 2023
revised: 10 12 2023
accepted: 14 12 2023
medline: 21 12 2023
pubmed: 21 12 2023
entrez: 20 12 2023
Statut: aheadofprint

Résumé

Guidelines and essential medicine lists (EMLs) bear similarities and differences in the process that lead to decisions. Access to essential medicines is central to achieve to universal health coverage. The World Health Organization (WHO) EML has guided prioritization of essential medicines globally for nearly 50 years, and national EMLs (NEMLs) exist in over 130 countries. Guideline and EML decisions, at WHO or national levels, are not always coordinated and aligned. We sought to explore challenges, and potential solutions, for decision-making to support trustworthy medicine selection for essential medicine lists from a GRADE Working Group perspective. We primarily focus on the WHO EML, however, our findings may be applicable to NEML decisions as well. We identified key challenges in connecting the EML to health guidelines by involving a broad group of stakeholders and assessing case studies including real applications to the WHO EML, South Africa NEML, and a multiple sclerosis guideline connected to a WHO EML application for MS treatments. To address challenges, we utilized the results of a survey and feedback from the stakeholders, and iteratively met as a project group. We drafted a conceptual framework of challenges and potential solutions. We presented a summary of the results for feedback to all attendees of the GRADE Working Group meetings in November 2022 (approximately 120 people) and in May 2023 (approximately 100 people) before finalizing the framework. We prioritized issues and insights/solutions that addressed the connections between the EML and health guidelines. Our suggested solutions include early planning alignment of guideline groups and EMLs, considering shared participation to strengthen linkage, further clarity on price/cost considerations, and using explicit shared criteria to make guideline and EML decisions. We also provide recommendations to strengthen the connection between WHO EML and NEMLs including through contextualization methods. This GRADE concept article, jointly developed by key stakeholders from the guidelines and EMLs field, identified key conceptual issues and potential solutions to support the continued advancement of trustworthy EMLs. Adopting structured decision criteria that can be linked to guideline recommendations bears the potential to advance health equity and gaps in availability of essential medicines within and between countries.

Identifiants

pubmed: 38123105
pii: S0895-4356(23)00339-6
doi: 10.1016/j.jclinepi.2023.111241
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

111241

Informations de copyright

Copyright © 2023. Published by Elsevier Inc.

Auteurs

Thomas Piggott (T)

Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada. Electronic address: thomas.piggott@medportal.ca.

Lorenzo Moja (L)

Department of Essential Medicines and Health Products, World Health Organization, Geneva, Switzerland.

Kristina Jenei (K)

Department of Health Policy, London School of Economics and Political Science, London, United Kingdom.

Tamara Kredo (T)

Health Systems Research Unit, South African Medical Research Council, Cape Town, South Africa.

Nicole Skoetz (N)

Evidence-Based Medicine, Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Rita Banzi (R)

Mario Negri Institute for Pharmacological Research IRCCS, Milan, Italy.

Dario Trapani (D)

Department of oncology and hematology, University of Milan, Milan, Italy; European institute of oncology, IRCCS, Milan, Italy.

Trudy Leong (T)

Health Systems Research Unit, South African Medical Research Council, Cape Town, South Africa.

Michael McCaul (M)

Centre for Evidence-based Health Care, Division of Epidemiology and Biostatistics, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.

John N Lavis (JN)

McMaster Health Forum, McMaster University, Hamilton, Canada.

Elie A Akl (EA)

Department of Internal Medicine, American University of Beirut, Lebanon.

Francesco Nonino (F)

IRCCS Istituto delle Scienze Neurologiche di Bologna, Unit of Epidemiology and Statistics.

Alfonso Iorio (A)

Mike Gent Chair in Healthcare Research Department of Research Methods, Evidence, and Impact.

Joanna Laurson-Doube (J)

Multiple Sclerosis International Federation, London SE1 0LX, UK.

Benedikt Huttner (B)

Department of Essential Medicines and Health Products, World Health Organization, Geneva, Switzerland.

Holger J Schünemann (HJ)

Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada.

Classifications MeSH